We developed the enzyme‐responsive peptide SAp‐CD28 to selectively target CD28‐overexpressing T‐ALL cells. Following phosphatase‐mediated activation, SAp‐CD28 undergoes conformational switching and nanooligomerization, resulting in the disruption of CD28 downstream signaling.
Jun Li +10 more
wiley +1 more source
CD9, a tetraspanin in cancer: biology and therapeutic promise in acute leukemia. [PDF]
Guého O +6 more
europepmc +1 more source
Molecular Minimal Residual Disease in Acute Myeloid Leukemia
M. Jongen‐Lavrencic +21 more
semanticscholar +1 more source
This study develops a GSH‐responsive nanoplatform, NP@Fla‐Cu, to co‐activate cuproptosis and excessive mitophagy in uveal melanoma. The nanoplatform enhances tumor‐specific copper delivery, depletes antioxidant defenses, and remodels the tumor immune microenvironment.
Hong Ren +5 more
wiley +1 more source
Acute leukemia during pregnancy: a single center experience with 23 cases, 2012-2022 and literature review. [PDF]
Liu W +9 more
europepmc +1 more source
Generation of CCR4/CD7 Bispecific CAR‐T Cells Resistant to Fratricide and Exhaustion
The applications of CAR T‐cell therapy in T‐cell malignancies face limitations such as fratricide, effector‐cell exhaustion, and antigen‐escape. Herein, we developed fratricide‐ and exhaustion‐resistant CAR‐T cells that targeted CCR4 and CD7 simultaneously, with optional EGFRt safety switch. Additionally, scRNA‐seq unveiled new molecular targets, which
Sile Li +10 more
wiley +1 more source
International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data. [PDF]
Turki AT +43 more
europepmc +1 more source
Somatic mutations precede acute myeloid leukemia years before diagnosis
Pinkal M. Desai +11 more
semanticscholar +1 more source
Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy
Cancer immunotherapy faces challenges in predicting treatment responses and understanding resistance mechanisms. Artificial intelligence (AI) and machine learning (ML) offer powerful solutions for cancer immunotherapy in patient stratification, biomarker discovery, treatment strategy optimization, and foundation model development.
Xinchao Wu +4 more
wiley +1 more source
Oral Necrotizing Ulcerations in Acute Leukemia Patients: Clinical Characteristics, Integrated Management, and Favorable Outcomes - A Case Series. [PDF]
Priandhika FH, Hidayat W, Fitriasari N.
europepmc +1 more source

